Bone cements for delivery of osteoinductive growth factors
用于输送骨诱导生长因子的骨水泥
基本信息
- 批准号:8196102
- 负责人:
- 金额:$ 31.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAnimal ModelAnimalsAreaAspirate substanceAutologousBindingBiocompatibleBiologicalBone CementsBone GrowthBone MarrowBone Morphogenetic ProteinsBone RegenerationBone TransplantationCalvariaCephalicClinicalCollagenCollagen Type IComplexDefectDentalDiffusionEquilibriumFractureGrowth FactorHealedHydroxyapatitesImplantIn SituInjectableInjection of therapeutic agentLeadLinkLiquid substanceMechanicsModelingMorphologyOperative Surgical ProceduresOral Surgical ProceduresOsteoblastsOsteogenesisPeptidesPhage DisplayPhasePhenotypePowder dose formProceduresPropertyRattusResearchRiskSafetySiteTensile StrengthTestingTimebonebone morphogenetic protein 2bone morphogenetic protein 6bone morphogenetic protein 7calcium phosphatehealingimplantationimprovedinorganic phosphateminimally invasivenoveloral surgery specialtyosteogenicosteoinductive factorprototyperepairedscaffoldstandard of caresuccesstetracalcium phosphate
项目摘要
DESCRIPTION (provided by applicant): Bone cements are widely used in maxillofacial surgery, repair of cranial defects, and dental fillings. Calcium phosphate bone cements are useful in many types of bone repair because they conform to the defect area, harden in situ, and can be resorbed and replaced by new bone. When the cements are injectable, they can also be used for minimally invasive surgery and filling narrow cavities and defects with limited accessibility. However, although calcium phosphate cements are biocompatible and set isothermally, they are only osteoconductive and do not possess osteoinductive properties. Attempts to augment the bioactivity of the material with growth factors have been limited by rapid diffusion of the growth factor away from the material. Therefore, there is a significant unmet clinical need for a bone cement that can retain and release osteoinductive factors at the site of healing. To that end, Affinergy has developed peptides with high affinities for osteoinductive growth factors. In this application, we propose to use our growth factor-binding peptides to capture autologous growth factors and deliver them with an injectable bone cement. In addition to oral and maxillofacial surgery, the final product could be modified for use in vertebroplasty, treatment of osteoporotic bones at risk of fracture, and minimally invasive repair of fresh fractures.
PUBLIC HEALTH RELEVANCE: Bone cements support the growth of bone in a variety of procedures, but they lack the ability to induce bone growth. Growth factors can enhance bone formation but are limited by the lack of optimal carriers. In this application, we propose to test a novel bone cement as a carrier for growth factors.
描述(申请人提供):骨水泥广泛应用于颌面外科、颅骨缺损修复和牙科填充。磷酸钙骨水泥可用于多种类型的骨修复,因为它们符合缺损区域,原位硬化,并且可以被新骨吸收和替代。当水泥可注射时,它们还可以用于微创手术以及填充狭窄的空腔和难以接近的缺陷。然而,尽管磷酸钙骨水泥具有生物相容性并等温凝固,但它们仅具有骨传导性,不具有骨诱导特性。用生长因子增强材料生物活性的尝试因生长因子从材料中快速扩散而受到限制。因此,对于能够在愈合部位保留和释放骨诱导因子的骨水泥存在显着的未满足的临床需求。为此,Affinergy 开发了对骨诱导生长因子具有高亲和力的肽。在此应用中,我们建议使用我们的生长因子结合肽来捕获自体生长因子并通过可注射骨水泥输送它们。除了口腔颌面外科手术之外,最终产品还可以进行修改,用于椎体成形术、治疗有骨折风险的骨质疏松性骨骼以及微创修复新鲜骨折。
公共健康相关性:骨水泥在各种手术中支持骨骼生长,但它们缺乏诱导骨骼生长的能力。生长因子可以增强骨形成,但由于缺乏最佳载体而受到限制。在此应用中,我们建议测试一种新型骨水泥作为生长因子的载体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN A HODGES其他文献
JONATHAN A HODGES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN A HODGES', 18)}}的其他基金
Novel clinical assay to rapidly monitor posaconazole levels in plasma
快速监测血浆中泊沙康唑水平的新型临床检测方法
- 批准号:
10246670 - 财政年份:2021
- 资助金额:
$ 31.84万 - 项目类别:
Bioactive Peptide Coatings for Synthetic Bone Grafts
用于合成骨移植物的生物活性肽涂层
- 批准号:
8500392 - 财政年份:2012
- 资助金额:
$ 31.84万 - 项目类别:
Bioactive Peptide Coatings for Synthetic Bone Grafts
用于合成骨移植物的生物活性肽涂层
- 批准号:
8200327 - 财政年份:2012
- 资助金额:
$ 31.84万 - 项目类别:
Peptide-coated skin substitutes for the treatment of burn injuries and wounds
用于治疗烧伤和伤口的肽涂层皮肤替代品
- 批准号:
9128000 - 财政年份:2012
- 资助金额:
$ 31.84万 - 项目类别:
Peptide-mediated Attachment of Drug-loaded Microparticles to Medical Devices
肽介导的载药微粒与医疗器械的附着
- 批准号:
7742051 - 财政年份:2009
- 资助金额:
$ 31.84万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:
10602826 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
GMP manufacturing and IND Filing of IN-002, a potent inhaled muco-trapping antibody therapy for Respiratory Syncytial Virus
IN-002 的 GMP 生产和 IND 备案,这是一种针对呼吸道合胞病毒的有效吸入粘液捕获抗体疗法
- 批准号:
10761398 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别:
Dual-Stimuli Responsive Antibiotic-Loaded Nanoparticles: A New Strategy to Overcome Antimicrobial Resistance
双刺激响应抗生素负载纳米颗粒:克服抗生素耐药性的新策略
- 批准号:
10703696 - 财政年份:2023
- 资助金额:
$ 31.84万 - 项目类别: